Sagayno, Louie Jean T.
HRN: 10-83-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2024
CEFUROXIME 750MG (VIAL)
12/19/2024
12/20/2024
IV
750MG
Q8 X 3 DOSES
S/P CLOSED REDUCTION AND PERCUTANEOUS PINNING
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes